SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-010643
Filing Date
2017-11-14
Accepted
2017-11-14 16:37:08
Documents
4
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT kbph_10q.htm 10-Q 354343
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF kbph_ex311.htm EX-31.1 19057
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF kbph_ex312.htm EX-31.2 18330
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE kbph_ex321.htm EX-32.1 9364
  Complete submission text file 0001654954-17-010643.txt   402221
Mailing Address 500 AUSTRALIAN AVENUE S. SUITE 600 WEST PALM BEACH FL 33401
Business Address 500 AUSTRALIAN AVENUE S. SUITE 600 WEST PALM BEACH FL 33401 416-955-0159
KYTO BIOPHARMA INC (Filer) CIK: 0001164888 (see all company filings)

IRS No.: 651086538 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50390 | Film No.: 171202182
SIC: 2834 Pharmaceutical Preparations